The products have been developed under the company’s Biotis Brain Heath Benefit brand
FrieslandCampina Ingredients is launching products targeting stress and anxiety within its Biotis Brain Health Benefit Solutions range.
The D-Stress sachet and Re-lax health shot are both built on FrieslandCampina Ingredients’ galacto-oligosaccharide (GOS), a dairy prebiotic which has reportedly been shown through scientific research to stimulate the growth of gut bacteria that could help consumers feel less stressed & anxious.
Vicky Davies, Global Marketing Director, Performance, Active and Medical Nutrition, at FrieslandCampina Ingredients said: “The global COVID-19 pandemic has really put mental wellbeing in the spotlight, elevating it to the same level of importance as other aspects of physical health. As such, we’re delighted to be expanding our Biotis Brain Health Benefit Solutions offering with concepts aimed at reducing stress and anxiety, which is something we all deal with at times. We’re looking forward to working closely with our customers – old and new – to bring these much-needed solutions to life.”
Jouke Veldman, Global Market Development Manager and Biotis Brain Health lead, said: “It’s key that products on the shelves not only appeal to consumers’ key concerns and fit into their lifestyles but are also proven to be effective. Our Biotis GOS is the most researched in the world, and our most recent clinical trials show that Biotis GOS can influence the gut microbiota composition by encouraging the growth of beneficial bacteria. Through the gut-brain axis, this translates into a reduction in feelings of stress and anxiety. What’s more, our Biotis GOS are versatile and stable, which means they can work in a variety of formats, making them a solution that works both for consumers and manufacturers.”
Biotis Brain Health Benefit Solutions aim to provide novel and viable ingredient solutions to growing consumer concerns around maintaining good mental wellbeing. The brand offers products for gut and brain health, with an immune health proposition set to launch in early 2021.
“Although its only six months since Biotis and Biotis Gut Health were launched, we’re proud to have already delivered innovative solutions that resonate with both customers and consumers in a short space of time,” added Davies. “It’s been possible thanks to our unique and detailed consumer insights and comprehensive scientific research and partnerships. Next year will see FrieslandCampina Ingredients add new propositions to the Biotis portfolio and should be a truly successful and progressive year for us and our partners as we continue to collaborate to meet the health and wellness needs of tomorrow.”